| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.2905 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.2905 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.2905 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.2905 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.2905 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.2905 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.2905 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.2905 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.2905 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.2905 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.2905 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.2905 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.2905 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.2905 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.2905 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.2905 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.2905 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.2905 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.2953 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.3615 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.3995 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.4433 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.4671 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.5135 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.5162 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.5593 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.5820 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.5839 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.5863 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.6124 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.6125 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.6339 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.6346 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.6379 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.6481 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.6647 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.6911 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.6915 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.6925 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.6983 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.7043 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.7113 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.7119 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.7230 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.7283 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.7303 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.7417 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.7510 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.7558 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.7568 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.7588 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.7954 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.8132 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.8229 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.8381 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.8427 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.8461 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.8499 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.8796 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.8805 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.8861 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.9337 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.9518 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.9618 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.9688 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.9734 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.9890 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.9915 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 0.9964 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.0036 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.0164 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.0189 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.0266 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.0303 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.0308 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.0488 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.0627 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.0735 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.0739 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.0907 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.1126 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.1209 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.1244 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.1267 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.1278 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.1656 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.2055 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.2155 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.2205 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.2471 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.2851 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.3416 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.3764 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.4013 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.4347 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.4635 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.4929 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.5067 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.5263 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.5325 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.5528 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.5824 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.5851 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.6047 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.6202 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.6509 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.7032 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.7119 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.7658 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.7861 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.8083 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 1.8090 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 2.2450 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 2.4241 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 2.4998 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 3.0816 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 3.0830 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 3.7925 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 4.1755 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 4.6626 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | methyl indole-3-acetate | 6.0136 | scaled units | Placebo | +71HR POST INFUSION |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|